Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 11/20 | 0.75 |
| ▸ | DRD4 | P21917 | 11/20 | 0.75 |
| ▸ | DRD3 | P35462 | 11/20 | 0.75 |
| ▸ | CHRM2 | P08172 | 10/20 | 0.75 |
| ▸ | CHRM4 | P08173 | 10/20 | 0.75 |
| ▸ | CHRM5 | P08912 | 10/20 | 0.75 |
| ▸ | CHRM1 | P11229 | 10/20 | 0.75 |
| ▸ | CHRM3 | P20309 | 10/20 | 0.75 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.64 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.64 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.64 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.64 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.55 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29119406 | 1.00 | DRD2 (0.75) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL3374155 | 0.98 | DRD2 (0.77) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL6200847 | 0.94 | DRD2 (0.84) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL12307233 | 0.89 | HTR2A (0.64) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL12307218 | 0.89 | HTR2A (0.64) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL12307238 | 0.89 | HTR2A (0.64) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL30483504 | 0.87 | DRD2 (0.69) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL17979351 | 0.87 | DRD2 (0.69) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL10615952 | 0.87 | HTR2A (0.66) | DRD2DRD4DRD3CHRM2CHRM4 | |
| SCHEMBL23339326 | 0.86 | HTR7 (0.63) | DRD2DRD4DRD3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1130017-B1 | Azole derivatives and their use as superoxide radical inhibitors | OTSUKA PHARMA CO LTD (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-0934937-B1 | Azole derivatives as superoxide radical inhibitor | OTSUKA PHARMA CO LTD (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-RE37556-E1 | (ALKOXYPHENYL)THIAZOLE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| EP-1130017-A2 | Azole derivatives and their use as superoxide radical inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2001-09-05 | — | — | EP | disclosed |
| US-6080764-A | PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2000-06-27 | — | — | US | disclosed |
| EP-0934937-A1 | Azole derivatives as superoxide radical inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
| US-5677319-A | THIAZOLE DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5643932-A | PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |